(Q45038784)

8 December 2017

title

The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats (English)

1 reference

8 December 2017

8

1 reference

8 December 2017

Sylvia Ortmann

1

1 reference

8 December 2017

Juliane Kampe

2

1 reference

8 December 2017

Matthias Gossel

3

1 reference

8 December 2017

Martin Bickel

4

1 reference

8 December 2017

Karl Geisen

5

1 reference

8 December 2017

Gerhard Jähne

6

1 reference

8 December 2017

Hans Jochen Lang

7

1 reference

8 December 2017

publication date

1 August 2004

1 reference

8 December 2017

1 reference

8 December 2017

volume

12

1 reference

8 December 2017

issue

8

1 reference

8 December 2017

page(s)

1290-1297

1 reference

Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Orlistat: selective inhibition of caloric absorption can affect long-term body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Anti-obesity drugs: a critical review of current therapies and future opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Amylin, food intake, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Characterization of the effects of pancreatic polypeptide in the regulation of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Self-selected macronutrient diet affects energy and glucose metabolism in brown fat-ablated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

New methods for calculating metabolic rate with special reference to protein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Regulation of body weight and carcass composition by sibutramine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Sibutramine produces dose-related weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Thermogenic effects of sibutramine and its metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Cholecystokinin antagonists: pharmacological and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Drug treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

How does sibutramine work?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Sibutramine: its mode of action and efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

Analysis of the anorectic efficacy of HMR1426 in rodents and its effects on gastric emptying in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.163

31 March 2020

Identifiers

DOI

10.1038/OBY.2004.163

1 reference

8 December 2017

1 reference